Publication
MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.
Jia-Yao Wang, Yan-Xiang Shao, Li-Li Yang, Hong-Shuai Li, Jia-Qi Liu, Rui-Zhi Liu, Shuang Zhang, Xiang Li, Ji-Yan Liu
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Emerging evidence suggests that combinations of antibody-drug conjugates (ADCs) and immune checkpoint inhibitors (ICIs) may be effective for advanced penile squamous cell carcinoma (PSCC). These findings support the translation of this strategy into the neoadjuvant setting, offering a novel…
Read on PubMedLinked entities
Linked entities (2)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT07518979registry_reference1.00
Candidate 1
- cancerMalignant Penile Neoplasmdictionary0.60
Registered trialsNCT07518979
Curated evidence
Evidence citing this paper (0)
Data not yet available